Supplementary Materials for the Fiscal Year Ending March 2027 Second Quarter Financial Results

Overview of Results

In the second quarter of the fiscal year ending March 2027, the Company recorded a significant decline in profits due to demand adjustments in the semiconductor-related business. However, strong performance in the measurement and weighing instruments business and the medical & healthcare devices business led to second-quarter cumulative net sales and operating income exceeding forecasts. Order backlog increased year-over-year, indicating clearer signs of recovery in the semiconductor-related field. The full-year forecast has been revised upward assuming contributions from measurement and weighing instruments and medical & healthcare devices, with projected net sales of 70,000 million yen and operating income of 8,000 million yen.

Segment and Regional Trends and Outlook

Semiconductor-related business in Japan continued to be affected by demand adjustments, resulting in decreased sales and profits. Measurement and weighing instruments remained solid, primarily in Japan. Medical & healthcare devices showed continued and expanding demand across all regions. In the Americas and Europe, medical & healthcare devices acted as growth drivers, and factors such as foreign exchange reimbursements contributed to profit improvement. The full-year outlook has been revised upward, but continued monitoring is necessary to achieve the fiscal year ending March 2027 targets.